(Q35203569)

7 August 2017

6 references

22 March 2019

17 June 2019

17 November 2019

20 November 2019

6 August 2020

4 September 2020

Ularitide for the treatment of acute decompensated heart failure: from preclinical to clinical studies (English)

1 reference

7 August 2017

3 references

22 March 2019

17 June 2019

4 September 2020

1 reference

17 November 2019

1 reference

20 November 2019

Natriuretic peptide A

1 reference

acute decompensated heart failure

6 August 2020

1 reference

5

Gerasimos Filippatos

1 reference

7 August 2017

2

Piotr Ponikowski

1 reference

7 August 2017

1

Stefan D Anker

1 reference

7 August 2017

4

W Frank Peacock

1 reference

7 August 2017

Veselin Mitrovic

3

1 reference

7 August 2017

language of work or name

1 reference

10 February 2015

1 reference

7 August 2017

21 March 2015

6 references

22 March 2019

17 June 2019

17 November 2019

20 November 2019

6 August 2020

4 September 2020

European Heart Journal

7 references

7 August 2017

22 March 2019

17 June 2019

17 November 2019

20 November 2019

6 August 2020

4 September 2020

36

1 reference

7 August 2017

issue

12

1 reference

7 August 2017

page(s)

715-723

1 reference

Creative Commons Attribution-NonCommercial 4.0 International

7 August 2017

copyright license

6 references

22 March 2019

17 June 2019

17 November 2019

20 November 2019

6 August 2020

on focus list of Wikimedia project

4 September 2020

ScienceSource

0 references

cites work

A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Effect of nesiritide in patients with acute decompensated heart failure

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Role of guanylate cyclase modulators in decompensated heart failure

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Renal effects of ularitide in patients with decompensated heart failure

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Natriuretic peptides and therapeutic applications

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Mechanisms of renal hyporesponsiveness to ANP in heart failure

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Regulation of natriuretic peptide (urodilatin) release in a human kidney cell line

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

The endocrine heart and natriuretic peptides: histochemistry, cell biology, and functional aspects of the renal urodilatin system

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Tissue distribution and localization of natriuretic peptide receptor subtypes in stroke-prone spontaneously hypertensive rats

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Increased renal natriuretic peptide (urodilatin) excretion in heart failure patients

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Hemodynamic effects of a single intravenous injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Urodilatin (CDD/ANP-95-126) is not biologically inactivated by a peptidase from dog kidney cortex membranes in contrast to atrial natriuretic peptide/cardiodilatin (alpha-hANP/CDD-99-126)

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Effects of ANP-(95-126) in dogs before and after induction of heart failure.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Evidence that urodilatin, rather than ANP, regulates renal sodium excretion

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Renal natriuretic peptide (urodilatin?) and atriopeptin: evolving concepts

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Differential regional expression of three natriuretic peptide receptor genes within primate tissues

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Haemodynamic and renal effects of urodilatin bolus injections in patients with congestive heart failure

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Haemodynamic and renal effects of urodilatin in healthy volunteers

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Roles of cephalic Na+ concentration and urodilatin in control of renal Na+ excretion

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: a double-blind, placebo-controlled, ascending-dose trial

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

The renal natriuretic peptide urodilatin is present in human kidney

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4368857

Isolation and structural analysis of "urodilatin", a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine

26 September 2018

1 reference

12 December 2020

Renal Effects of ANF (95-126), A New Atrial Peptide Analogue, in Dogs With Experimental Heart Failure

1 reference

12 December 2020

Urodilatin, a kidney-derived natriuretic factor, is excreted with a circadian rhythm and is stimulated by saline infusion in man

1 reference

12 December 2020

Renal and systemic effects of urodilatin in rats with high-output heart failure

1 reference

12 December 2020

Development and application of a urodilatin (CDD/ANP-95-126)-specific radioimmunoassay

1 reference

12 December 2020

Immunocytochemical localization of ProANF 1-30, ProANF 31-67, atrial natriuretic factor and urodilatin in the human kidney

1 reference

12 December 2020

Efficacy of prolonged infusion of urodilatin [ANP-(95-126)] in patients with congestive heart failure

1 reference

12 December 2020

Urodilatin (ularitide, INN): a potent bronchodilator in asthmatic subjects

1 reference

12 December 2020

Urodilatin is involved in sodium homeostasis and exerts sodium-state-dependent natriuretic and diuretic effects

1 reference

12 December 2020

Effect of urodilatin infusion on renal haemodynamics, tubular function and vasoactive hormones

1 reference

12 December 2020

[Renal urodilatin secretion is associated with diuresis and natriuresis after spontaneous, supraventricular tachycardia]

1 reference

12 December 2020

Haemodynamic and clinical effects of ularitide in decompensated heart failure

1 reference

12 December 2020

Identifiers

DOI

10.1093/EURHEARTJ/EHU484

1 reference

7 August 2017

1 reference

7 August 2017

1 reference